Robert Huber
Corporate Officer/Principal chez University of Duisburg-Essen
Profil
Robert Huber is the founder of SuppreMol GmbH (founded in 2002).
He is currently a Professor at Technische Universität München, the University of Cardiff, the University of Duisburg-Essen, the University of Seville, Korean German Institute of Technology, and Universitat Autònoma de Barcelona.
Dr. Huber's former positions include Director at THERAMetrics holding AG (2008-2011) and Scientific Director at Max Planck Institute of Biochemistry (1972-2005).
Dr. Huber received his doctorate degree from Technische Universität München.
Dr. Huber is also the founder of Proteros biostructures GmbH.
Postes actifs de Robert Huber
| Sociétés | Poste | Début |
|---|---|---|
| University of Duisburg-Essen | Corporate Officer/Principal | 21/06/2010 |
| University of Cardiff | Corporate Officer/Principal | 21/06/2010 |
| University of Seville | Corporate Officer/Principal | 21/06/2010 |
| Universitat Autònoma de Barcelona | Corporate Officer/Principal | 21/06/2010 |
| Korean German Instittue of Technology | Corporate Officer/Principal | 12/01/2011 |
| Technische Universität München | Corporate Officer/Principal | - |
Anciens postes connus de Robert Huber
| Sociétés | Poste | Fin |
|---|---|---|
THERAMetrics holding AG
 THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland. | Directeur/Membre du Conseil | 26/05/2011 |
| Max Planck Institute of Biochemistry | Directeur Technique/Scientifique/R&D | 01/01/2005 |
Proteros biostructures GmbH
 Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Fondateur | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formation de Robert Huber
| Technische Universität München | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
THERAMetrics holding AG
THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland. | Health Technology |
SuppreMol GmbH
 SuppreMol GmbH Pharmaceuticals: MajorHealth Technology SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany. | Health Technology |
Proteros biostructures GmbH
Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Health Services |
